HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Claudio N Soares Selected Research

Desvenlafaxine Succinate

1/2020Predictors of functional response and remission with desvenlafaxine 50 mg and 100 mg: a pooled analysis of randomized, placebo-controlled studies in patients with major depressive disorder.
1/2019Categorical improvement in functional impairment in depressed patients treated with desvenlafaxine.
1/2019Cerebral cortical thickness after treatment with desvenlafaxine succinate in major depressive disorder.
12/2014Predictors of functional response and remission with desvenlafaxine 50 mg/d in patients with major depressive disorder.
2/2014Early improvement in depressive symptoms with desvenlafaxine 50 mg/d as a predictor of treatment success in patients with major depressive disorder.
1/2012Assessing the relationship between functional impairment/recovery and depression severity: a pooled analysis.
3/2011Open-label treatment with desvenlafaxine in postmenopausal women with major depressive disorder not responding to acute treatment with desvenlafaxine or escitalopram.
7/2010Desvenlafaxine and escitalopram for the treatment of postmenopausal women with major depressive disorder.
6/2010Analysis by age and sex of efficacy data from placebo-controlled trials of desvenlafaxine in outpatients with major depressive disorder.
10/2009Assessing the efficacy of desvenlafaxine for improving functioning and well-being outcome measures in patients with major depressive disorder: a pooled analysis of 9 double-blind, placebo-controlled, 8-week clinical trials.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Claudio N Soares Research Topics

Disease

27Major Depressive Disorder (Major Depressive Disorders)
11/2022 - 01/2005
6Mood Disorders (Mood Disorder)
01/2019 - 01/2002
5Premenstrual Dysphoric Disorder
02/2018 - 09/2004
4Premenstrual Syndrome (Premenstrual Tension)
02/2018 - 09/2008
4Hot Flashes
10/2011 - 02/2008
3Sleep Initiation and Maintenance Disorders (Insomnia)
01/2012 - 12/2006
3Depressive Disorder (Melancholia)
09/2006 - 01/2002
2Treatment-Resistant Depressive Disorder
01/2021 - 08/2020
2Postpartum Depression (Post-Natal Depression)
12/2013 - 09/2005
1Neoplasms (Cancer)
01/2021
1Testicular Neoplasms (Testicular Cancer)
01/2021
1Syndrome (Syndromes)
01/2020
1Anhedonia
01/2020
1Type 2 Diabetes Mellitus (MODY)
01/2019
1Insulin Resistance
01/2019
1Inflammation (Inflammations)
12/2018
1Cognitive Dysfunction
07/2010
1Fatigue
10/2009
1Phobic Disorders (Phobia)
10/2009
1Substance-Related Disorders (Drug Abuse)
10/2009
1Spontaneous Abortion (Miscarriage)
10/2009
1Medically Unexplained Symptoms
07/2007
1Pain (Aches)
06/2007

Drug/Important Bio-Agent (IBA)

14Antidepressive Agents (Antidepressants)IBA
01/2021 - 01/2005
10Desvenlafaxine SuccinateFDA Link
01/2020 - 10/2009
9Biomarkers (Surrogate Marker)IBA
11/2022 - 01/2018
6Hormones (Hormone)IBA
02/2011 - 01/2002
5EscitalopramFDA Link
01/2020 - 07/2010
4Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA
02/2018 - 09/2004
4Estrogens (Estrogen)FDA Link
11/2011 - 04/2003
4Biological ProductsIBA
06/2010 - 09/2008
3Serotonin (5 Hydroxytryptamine)IBA
11/2011 - 07/2010
2Aripiprazole (Abilify)FDA Link
01/2020 - 01/2019
2Duloxetine Hydrochloride (Cymbalta)FDA Link
01/2019 - 06/2007
2Tuberculin (PPD)IBA
12/2013 - 09/2005
2Quetiapine Fumarate (Seroquel)FDA Link
02/2013 - 10/2010
2Eszopiclone (Lunesta)FDA Link
01/2012 - 12/2006
2Paroxetine (Paxil)FDA LinkGeneric
02/2008 - 09/2004
2Bupropion (Wellbutrin)FDA LinkGeneric
07/2007 - 09/2005
1EndocannabinoidsIBA
11/2022
16-sulfatoxymelatoninIBA
01/2019
1Insulin (Novolin)FDA Link
01/2019
1Brain-Derived Neurotrophic Factor (BDNF)IBA
12/2018
13-nitrotyrosineIBA
12/2018
1HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA
12/2018
1Thiobarbituric Acid Reactive SubstancesIBA
12/2018
1Proteins (Proteins, Gene)FDA Link
12/2018
1Sulfhydryl Compounds (Thiols)IBA
12/2018
1Combined Oral ContraceptivesIBA
02/2018
1Serotonin and Noradrenaline Reuptake InhibitorsIBA
02/2018
1Estrogen ReceptorsIBA
12/2013
1Norepinephrine (Noradrenaline)FDA LinkGeneric
07/2010
1Prescription DrugsIBA
10/2009
1Oral ContraceptivesIBA
12/2007
1Ethinyl Estradiol (Estinyl)FDA LinkGeneric
09/2006
1Progestins (Progestagens)IBA
09/2006
1Norethindrone Acetate (Norlutate)FDA LinkGeneric
09/2006
1Fluoxetine (Prozac)FDA LinkGeneric
01/2005
1Venlafaxine Hydrochloride (Effexor)FDA LinkGeneric
10/2004
1CitalopramFDA LinkGeneric
04/2003
1Gonadal Steroid Hormones (Sex Hormones)IBA
01/2002

Therapy/Procedure

6Therapeutics
01/2019 - 04/2003
1Orchiectomy (Orchidectomy)
01/2021
1Aftercare (After-Treatment)
01/2019
1Drug Therapy (Chemotherapy)
02/2018